Nouscom Company
Nouscom is a developer of an immunotherapy platform that aims to create modified viral vector vaccines for cancer treatment. The company's platform makes use of a portfolio of engineered viral vectors that have been optimized for the efficient expression of long strings of tumor neoantigens. It also includes a toolkit for inducing broad and potent antitumor T-cell responses, allowing patients to boost cancer-specific cellular immunity.
Investors
Connections
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Founded Date:
2015-01-01
Industry:
Vaccines & Immunotherapy
Employee Number:
11-50
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41 612-01-18-31
Investors:
Abingworth, Andera Partners, Bpifrance, EQT Life Sciences, Versant Ventures
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
Founders:
Cinzia Traboni, Elisa Scarduelli, Riccardo Cortese